Tomas Kiselak - Net Worth and Insider Trading

Over the past 18 months, Tomas Kiselak made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net purchase of 1,631,015 shares made by Fairmount Healthcare Fund Ii Gp Llc , and a net sale of 2,272 shares made by Jennifer Tousignant .

In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,272 shares of Viridian Therapeutics Inc (VRDN) were sold and 1,631,015 shares were bought by its insiders, resulting in a net purchase of 1,628,743 shares.

Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Tomas Kiselak made no insider transaction in Spyre Therapeutics Inc (SYRE). Other recent insider transactions involving Spyre Therapeutics Inc (SYRE) include a net sale of 165,000 shares made by Cameron Turtle , a net sale of 78,428 shares made by Scott L Burrows , and a net sale of 102,958 shares made by Sheldon Sloan .

In summary, during the past 3 months, insiders sold 4,826,948 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 4,826,948 shares. During the past 18 months, 5,154,167 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,154,167 shares.

Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Tomas Kiselak made no insider transaction in Apogee Therapeutics Inc (APGE). Other recent insider transactions involving Apogee Therapeutics Inc (APGE) include a net sale of 135,245 shares made by Carl Dambkowski , a net sale of 27,500 shares made by Jane Henderson , and a net sale of 280,000 shares made by Michael Thomas Henderson .

In summary, during the past 3 months, insiders sold 182,900 shares of Apogee Therapeutics Inc (APGE) in total and bought 0 shares, with a net sale of 182,900 shares. During the past 18 months, 2,192,745 shares of Apogee Therapeutics Inc (APGE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,192,745 shares.

Apogee Therapeutics Inc (APGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Tomas Kiselak made no insider transaction in Zenas BioPharma Inc (ZBIO). Other recent insider transactions involving Zenas BioPharma Inc (ZBIO) include a net purchase of 392,928 shares made by Moulder Leon O Jr , a net purchase of 426,736 shares made by Hongbo Lu , and a net purchase of 466,219 shares made by Fairmount Healthcare Fund Ii L.p. .

In summary, during the past 3 months, insiders sold 0 shares of Zenas BioPharma Inc (ZBIO) in total and bought 60,000 shares, with a net purchase of 60,000 shares. During the past 18 months, 0 shares of Zenas BioPharma Inc (ZBIO) were sold and 1,612,471 shares were bought by its insiders, resulting in a net purchase of 1,612,471 shares.

Zenas BioPharma Inc (ZBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Tomas Kiselak made no insider transaction in Oruka Therapeutics Inc (ORKA). Other recent insider transactions involving Oruka Therapeutics Inc (ORKA) include a net sale of 57,588 shares made by Joana Goncalves , a net sale of 29,200 shares made by Laura Lee Sandler , and a net sale of 32,125 shares made by Arjun Agarwal .

In summary, during the past 3 months, insiders sold 3,755,149 shares of Oruka Therapeutics Inc (ORKA) in total and bought 0 shares, with a net sale of 3,755,149 shares. During the past 18 months, 3,817,247 shares of Oruka Therapeutics Inc (ORKA) were sold and 122,882 shares were bought by its insiders, resulting in a net sale of 3,694,365 shares.

Oruka Therapeutics Inc (ORKA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Tomas Kiselak made no insider transaction in Crescent Biopharma Inc (CBIO). Other recent insider transactions involving Crescent Biopharma Inc (CBIO) include a net purchase of 2,213,450 shares made by Fairmount Healthcare Fund Ii L.p. , a net sale of 42,305 shares made by Joshua T Brumm , and a net sale of 20,549 shares made by Jonathan Mcneill .

In summary, during the past 3 months, insiders sold 68,156 shares of Crescent Biopharma Inc (CBIO) in total and bought 853,450 shares, with a net purchase of 785,294 shares. During the past 18 months, 68,156 shares of Crescent Biopharma Inc (CBIO) were sold and 2,213,450 shares were bought by its insiders, resulting in a net purchase of 2,145,294 shares.

Crescent Biopharma Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Tomas Kiselak made no insider transaction in Dianthus Therapeutics Inc (DNTH). Other recent insider transactions involving Dianthus Therapeutics Inc (DNTH) include a net sale of 193,840 shares made by Ryan Savitz , a net sale of 256,898 shares made by Simrat Randhawa , and a net sale of 28,792 shares made by Paula Soteropoulos .

In summary, during the past 3 months, insiders sold 253,779 shares of Dianthus Therapeutics Inc (DNTH) in total and bought 0 shares, with a net sale of 253,779 shares. During the past 18 months, 842,130 shares of Dianthus Therapeutics Inc (DNTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 842,130 shares.

Dianthus Therapeutics Inc (DNTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Tomas Kiselak made no insider transaction in Jade Biosciences Inc (JBIO). Other recent insider transactions involving Jade Biosciences Inc (JBIO) include a net purchase of 6,000 shares made by Tom Frohlich ,

In summary, during the past 3 months, insiders sold 0 shares of Jade Biosciences Inc (JBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jade Biosciences Inc (JBIO) were sold and 6,000 shares were bought by its insiders, resulting in a net purchase of 6,000 shares.

Jade Biosciences Inc (JBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Tomas Kiselak made no insider transaction in Damora Therapeutics Inc (DMRA). Other recent insider transactions involving Damora Therapeutics Inc (DMRA) include a net sale of 1,435 shares made by Hans T. Schambye , a net sale of 505 shares made by Garrett Winslow , and a net sale of 282 shares made by Lori Firmani .

In summary, during the past 3 months, insiders sold 245 shares of Damora Therapeutics Inc (DMRA) in total and bought 0 shares, with a net sale of 245 shares. During the past 18 months, 2,222 shares of Damora Therapeutics Inc (DMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,222 shares.

Damora Therapeutics Inc (DMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.